Johnson RE  *, Oldroyd ME, Ahmed SS, Gieseler H, Lewis LM  *. 2010. Use of Manometric Temperature Measurements (MTM) to Characterize the Freeze- Drying Behavior of Amorphous Protein Formulations. J Pharm Sci 99(6):2863-2873.

Schneid S, Gieseler H  *, Kessler WJ, Luthra SA, Pikal MJ. 2011. Optimization of the Secondary Drying Step in Freeze Drying Using TDLAS Technology. AAPS PharmSciTech 12(1):379-387.

Schneid S, Stärtzel P, Lettner P, Gieseler H  *. 2011. Robustness Testing in Pharmaceutical Freeze-Drying: Interrelation of Process Conditions and Product Quality Attributes Studied for a Vaccine Formulation. Pharm Dev Technol 16(6): 583-90.

Beirowski J, Inghelbrecht S, Arien A, Gieseler H  *. 2011. Freeze-drying of nanosuspensions, 1: Freezing rate versus formulation design as critical factors to preserve the original particle size distribution. J Pharm Sci 100(5):1958-1968.

Beirowski J, Inghelbrecht S, Arien A, Gieseler H  *. 2011. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design. J Pharm Sci 100(10):4471-4481.

Beirowski J, Inghelbrecht S, Arien A, Gieseler H *. 2012. Freeze-drying of nanosuspensions, part 3: Investigation of factors compromising storage stability of highly concentrated drug nanosuspensions. J Pharm Sci 101(1):354-362.